Use of Antithrombotic Agents During Pregnancy Conferences

authors

• Ginsberg, Jeffrey S
• Hirsh, Jack

status

• published 

publication date

• October 1995

has subject area

• 1103 Clinical Sciences (FoR)
• Clinical Trials as Topic (MeSH)
• Female (MeSH)
• Fibrinolytic Agents (MeSH)
• Heart Valve Prosthesis (MeSH)
• Humans (MeSH)
• Pregnancy (MeSH)
• Pregnancy Complications, Cardiovascular (MeSH)
• Respiratory System (Science Metrix)
• Thromboembolism (MeSH)

published in

• Chest  Journal

presented at event

• 4th American-College-of-Chest-Physicians Consensus Conference on Antithrombotic Therapy  Conference

keywords

• 2ND TRIMESTER
• ANTICOAGULANT-THERAPY
• ANTIPHOSPHOLIPID ANTIBODIES
• Critical Care Medicine
• DEEP-VEIN THROMBOSIS
• General & Internal Medicine
• Life Sciences & Biomedicine
• MOLECULAR-WEIGHT HEPARIN
• RECURRENT THROMBOEMBOLISM
• Respiratory System
• SUBCUTANEOUS HEPARIN
• SYSTEMIC LUPUS-ERYTHEMATOSUS
• Science & Technology
• VENOUS THROMBOSIS
• WARFARIN SODIUM

Digital Object Identifier (DOI)

• 10.1378/chest.108.4_supplement.305s

PubMed ID

• 7555185

start page

• 305S

end page

• 311S

volume

• 108

issue

• 4